HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.

Cargill, Tamsin; Cicconi, Paola; Brown, Anthony; Holland, Louise; Karanth, Benaka; Rutkowski, Kathryn; Ashwin, Emily; Mehta, Reena; Chinnakannan, Senthil; Sebastian, Sarah; Bussey, Louise; Sorensen, Henrik; Klenerman, Paul; Evans, Thomas; Barnes, Eleanor.

Cargill T; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Cicconi P; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Brown A; Jenner Vaccine Trials Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, UK.
Holland L; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Karanth B; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Rutkowski K; Jenner Vaccine Trials Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, UK.
Ashwin E; Vaccitech, Harwell, Didcot, UK.
Mehta R; Vaccitech, Harwell, Didcot, UK.
Chinnakannan S; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Sebastian S; Jenner Vaccine Trials Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, UK.
Bussey L; Vaccitech, Harwell, Didcot, UK.
Sorensen H; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Klenerman P; Vaccitech, Harwell, Didcot, UK.
Evans T; Vaccitech, Harwell, Didcot, UK.
Barnes E; Vaccitech, Harwell, Didcot, UK.